21 related articles for article (PubMed ID: 10987198)
1. Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.
Kotani K; Kawada N
Gut Liver; 2024 Jan; 18(1):27-39. PubMed ID: 37842727
[TBL] [Abstract][Full Text] [Related]
2. Biology of portal hypertension.
McConnell M; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):11-23. PubMed ID: 29075990
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
Thirunavukkarasu C; Yang Y; Subbotin VM; Harvey SA; Fung J; Gandhi CR
Gut; 2004 Jul; 53(7):1010-9. PubMed ID: 15194653
[TBL] [Abstract][Full Text] [Related]
4. Activation of the hepatic endothelin-system in rats with biliary liver fibrosis.
Rothermund L; Cho JJ; Leggewie S; Schwarz A; Bauer C; Paul M; Neumayer HH; Schuppan D; Hocher B
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S270-3. PubMed ID: 11078396
[TBL] [Abstract][Full Text] [Related]
5. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis.
Cho JJ; Hocher B; Herbst H; Jia JD; Ruehl M; Hahn EG; Riecken EO; Schuppan D
Gastroenterology; 2000 Jun; 118(6):1169-78. PubMed ID: 10833492
[TBL] [Abstract][Full Text] [Related]
6. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
7. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1.
Jia JD; Bauer M; Cho JJ; Ruehl M; Milani S; Boigk G; Riecken EO; Schuppan D
J Hepatol; 2001 Sep; 35(3):392-8. PubMed ID: 11592601
[TBL] [Abstract][Full Text] [Related]
9. Multiple hepatic functions of endothelin-1: physiopathological relevance.
Mallat A; Lotersztajn S
J Hepatol; 1996 Sep; 25(3):405-13. PubMed ID: 8895023
[No Abstract] [Full Text] [Related]
10. Endothelin-1 and tumour development.
Asham EH; Loizidou M; Taylor I
Eur J Surg Oncol; 1998 Feb; 24(1):57-60. PubMed ID: 9542519
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the hepatic endothelin system in advanced biliary fibrosis in rats.
Rothermund L; Leggewie S; Schwarz A; Thöne-Reinecke C; Cho JJ; Bauer C; Paul M; Neumayer HH; Schuppan D; Hocher B
Clin Chem Lab Med; 2000 Jun; 38(6):507-12. PubMed ID: 10987198
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
